"Hydroxylamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A colorless inorganic compound (HONH2) used in organic synthesis and as a reducing agent, due to its ability to donate nitric oxide.
Descriptor ID |
D019811
|
MeSH Number(s) |
D01.625.062.437
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hydroxylamine".
Below are MeSH descriptors whose meaning is more specific than "Hydroxylamine".
This graph shows the total number of publications written about "Hydroxylamine" by people in this website by year, and whether "Hydroxylamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
1999 | 1 | 1 | 2 |
2005 | 1 | 1 | 2 |
2008 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydroxylamine" by people in Profiles.
-
Quantitation of the effect of hydroxylamine on rhodopsin palmitylation. Photochem Photobiol. 2008 Jul-Aug; 84(4):949-55.
-
Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J Biol Chem. 2005 Oct 21; 280(42):35562-70.
-
Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes. Biochem Pharmacol. 2005 Jul 15; 70(2):275-86.
-
Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals? J Pharmacol Exp Ther. 1999 Dec; 291(3):1356-64.
-
Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions. J Pharmacol Exp Ther. 1999 Mar; 288(3):951-9.
-
Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone. Biochem Pharmacol. 1998 Mar 15; 55(6):803-10.
-
Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine. Biochem Pharmacol. 1995 Mar 30; 49(7):921-7.
-
Phosphorylation and reaction intermediates of the prokaryotic Ca(2+)-ATPase. J Biol Chem. 1993 Sep 25; 268(27):20590-7.